460 related articles for article (PubMed ID: 25452213)
21. Design, Synthesis, and Evaluation of New Selective NM23-H2 Binders as c-MYC Transcription Inhibitors via Disruption of the NM23-H2/G-Quadruplex Interaction.
Wang YQ; Huang ZL; Chen SB; Wang CX; Shan C; Yin QK; Ou TM; Li D; Gu LQ; Tan JH; Huang ZS
J Med Chem; 2017 Aug; 60(16):6924-6941. PubMed ID: 28714689
[TBL] [Abstract][Full Text] [Related]
22. Inducement of G-quadruplex DNA forming and down-regulation of oncogene c-myc by bile acid-amino acid conjugate-BAA.
Tian M; Zhang X; Li Y; Ju Y; Xiang J; Zhao C; Tang Y
Nucleosides Nucleotides Nucleic Acids; 2010 Mar; 29(3):190-9. PubMed ID: 20408050
[TBL] [Abstract][Full Text] [Related]
23. Microwave-assisted synthesis of phenanthroimidazole derivatives as stabilizer of c-myc G-quadruplex DNA.
Liao S; Zhang Z; Wu Q; Wang X; Mei W
Bioorg Med Chem; 2014 Nov; 22(22):6503-8. PubMed ID: 25440731
[TBL] [Abstract][Full Text] [Related]
24. Structure-based design of platinum(II) complexes as c-myc oncogene down-regulators and luminescent probes for G-quadruplex DNA.
Wang P; Leung CH; Ma DL; Yan SC; Che CM
Chemistry; 2010 Jun; 16(23):6900-11. PubMed ID: 20437426
[TBL] [Abstract][Full Text] [Related]
25. A Nucleus-Imaging Probe That Selectively Stabilizes a Minor Conformation of c-MYC G-quadruplex and Down-regulates c-MYC Transcription in Human Cancer Cells.
Panda D; Debnath M; Mandal S; Bessi I; Schwalbe H; Dash J
Sci Rep; 2015 Aug; 5():13183. PubMed ID: 26286633
[TBL] [Abstract][Full Text] [Related]
26. A cyclometallated iridium(III) complex as a c-myc G-quadruplex stabilizer and down-regulator of c-myc oncogene expression.
Yang H; Ma VP; Chan DS; He HZ; Leung CH; Ma DL
Curr Med Chem; 2013; 20(4):576-82. PubMed ID: 23116145
[TBL] [Abstract][Full Text] [Related]
27. Anticancer activity and cellular repression of c-MYC by the G-quadruplex-stabilizing 11-piperazinylquindoline is not dependent on direct targeting of the G-quadruplex in the c-MYC promoter.
Boddupally PV; Hahn S; Beman C; De B; Brooks TA; Gokhale V; Hurley LH
J Med Chem; 2012 Jul; 55(13):6076-86. PubMed ID: 22691117
[TBL] [Abstract][Full Text] [Related]
28. Syntheses and Evaluation of New Bisacridine Derivatives for Dual Binding of G-Quadruplex and i-Motif in Regulating Oncogene
Kuang G; Zhang M; Kang S; Hu D; Li X; Wei Z; Gong X; An LK; Huang ZS; Shu B; Li D
J Med Chem; 2020 Sep; 63(17):9136-9153. PubMed ID: 32787078
[TBL] [Abstract][Full Text] [Related]
29. Curcumin analogs exhibit anti-cancer activity by selectively targeting G-quadruplex forming c-myc promoter sequence.
Pandya N; Khan E; Jain N; Satham L; Singh R; Makde RD; Mishra A; Kumar A
Biochimie; 2021 Jan; 180():205-221. PubMed ID: 33188859
[TBL] [Abstract][Full Text] [Related]
30. Novel molecular mechanism for actinomycin D activity as an oncogenic promoter G-quadruplex binder.
Kang HJ; Park HJ
Biochemistry; 2009 Aug; 48(31):7392-8. PubMed ID: 19496619
[TBL] [Abstract][Full Text] [Related]
31. Perylene and coronene derivatives binding to G-rich promoter oncogene sequences efficiently reduce their expression in cancer cells.
Micheli E; Altieri A; Cianni L; Cingolani C; Iachettini S; Bianco A; Leonetti C; Cacchione S; Biroccio A; Franceschin M; Rizzo A
Biochimie; 2016 Jun; 125():223-31. PubMed ID: 27086081
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and in Vitro Evaluation of Novel 5-Nitroindole Derivatives as c-Myc G-Quadruplex Binders with Anticancer Activity.
Nimbarte VD; Wirmer-Bartoschek J; Gande SL; Alshamleh I; Seibert M; Nasiri HR; Schnütgen F; Serve H; Schwalbe H
ChemMedChem; 2021 May; 16(10):1667-1679. PubMed ID: 33508167
[TBL] [Abstract][Full Text] [Related]
33. Syntheses and evaluation of new acridone derivatives for selective binding of oncogene c-myc promoter i-motifs in gene transcriptional regulation.
Shu B; Cao J; Kuang G; Qiu J; Zhang M; Zhang Y; Wang M; Li X; Kang S; Ou TM; Tan JH; Huang ZS; Li D
Chem Commun (Camb); 2018 Feb; 54(16):2036-2039. PubMed ID: 29411851
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluation of disubstituted amidoxanthones as potential telomeric G-quadruplex DNA-binding and apoptosis-inducing agents.
Shen R; Chen Y; Li Z; Qi H; Wang Y
Bioorg Med Chem; 2016 Feb; 24(4):619-26. PubMed ID: 26740156
[TBL] [Abstract][Full Text] [Related]
35. Solution equilibria of cytosine- and guanine-rich sequences near the promoter region of the n-myc gene that contain stable hairpins within lateral loops.
Benabou S; Ferreira R; Aviñó A; González C; Lyonnais S; Solà M; Eritja R; Jaumot J; Gargallo R
Biochim Biophys Acta; 2014 Jan; 1840(1):41-52. PubMed ID: 24012973
[TBL] [Abstract][Full Text] [Related]
36. Spectroscopic and biological studies of phenanthroline compounds: selective recognition of gene-promoter G-quadruplex DNAs preferred over duplex DNA.
Wang L; Wei C
Chem Biodivers; 2013 Jun; 10(6):1154-64. PubMed ID: 23776031
[TBL] [Abstract][Full Text] [Related]
37. Microwave-assisted synthesis of ruthenium(II) complexes with alkynes as potential inhibitor by selectively recognizing c-myc G-quadruplex DNA.
Zhang S; Wu Q; Zhang H; Wang Q; Wang X; Mei W; Wu X; Zheng W
J Inorg Biochem; 2017 Nov; 176():113-122. PubMed ID: 28888786
[TBL] [Abstract][Full Text] [Related]
38. Utilization of circular dichroism and electrospray ionization mass spectrometry to understand the formation and conversion of G-quadruplex DNA at the human c-myb proto-oncogene.
Fu H; Yang P; Hai J; Li H
Spectrochim Acta A Mol Biomol Spectrosc; 2018 Oct; 203():70-76. PubMed ID: 29860170
[TBL] [Abstract][Full Text] [Related]
39. Novel interaction of the Z-DNA binding domain of human ADAR1 with the oncogenic c-Myc promoter G-quadruplex.
Kang HJ; Le TV; Kim K; Hur J; Kim KK; Park HJ
J Mol Biol; 2014 Jul; 426(14):2594-604. PubMed ID: 24813121
[TBL] [Abstract][Full Text] [Related]
40. Structure-based design of flavone derivatives as c-myc oncogene down-regulators.
Yang H; Zhong HJ; Leung KH; Chan DS; Ma VP; Fu WC; Nanjunda R; Wilson WD; Ma DL; Leung CH
Eur J Pharm Sci; 2013 Jan; 48(1-2):130-41. PubMed ID: 23127826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
